These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1714920)

  • 1. Hypothesis: antigen-specific T cells prime central nervous system endothelium for recruitment of nonspecific inflammatory cells to effect autoimmune demyelination.
    Cross AH; Cannella B; Brosnan CF; Raine CS
    J Neuroimmunol; 1991 Sep; 33(3):237-44. PubMed ID: 1714920
    [No Abstract]   [Full Text] [Related]  

  • 2. T cell approach to demyelinating diseases.
    Wekerle H; Fierz W
    Springer Semin Immunopathol; 1985; 8(1-2):97-110. PubMed ID: 3890239
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular and molecular mechanisms of autoimmune demyelination in the central nervous system.
    Glynn P; Linington C
    Crit Rev Neurobiol; 1989; 4(4):367-85. PubMed ID: 2655941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination.
    Raine CS; Cannella B; Duijvestijn AM; Cross AH
    Lab Invest; 1990 Oct; 63(4):476-89. PubMed ID: 1700193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system endothelial cell-polymorphonuclear cell interactions during autoimmune demyelination.
    Cross AH; Raine CS
    Am J Pathol; 1991 Dec; 139(6):1401-9. PubMed ID: 1750510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of immunopathology in murine models of central nervous system demyelinating disease.
    Ercolini AM; Miller SD
    J Immunol; 2006 Mar; 176(6):3293-8. PubMed ID: 16517694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic models of TNF induced demyelination.
    Akassoglou K; Bauer J; Kassiotis G; Lassmann H; Kollias G; Probert L
    Adv Exp Med Biol; 1999; 468():245-59. PubMed ID: 10635034
    [No Abstract]   [Full Text] [Related]  

  • 8. Dominance of autoreactive T cell-mediated delayed-type hypersensitivity or antibody-mediated demyelination results in distinct forms of experimental autoimmune neuritis in the Lewis rat.
    Taylor JM; Pollard JD
    J Neuropathol Exp Neurol; 2001 Jun; 60(6):637-46. PubMed ID: 11398840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central nervous system demyelination and remyelination in multiple sclerosis and viral models of disease.
    Rodriguez M
    J Neuroimmunol; 1992 Oct; 40(2-3):255-63. PubMed ID: 1430155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term remyelination fails to reconstitute normal thickness of central myelin sheaths.
    Ludwin SK; Maitland M
    J Neurol Sci; 1984 May; 64(2):193-8. PubMed ID: 6747666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice.
    Katz-Levy Y; Neville KL; Girvin AM; Vanderlugt CL; Pope JG; Tan LJ; Miller SD
    J Clin Invest; 1999 Sep; 104(5):599-610. PubMed ID: 10487774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial peptides and superantigens in the pathogenesis of autoimmune diseases of the central nervous system.
    Brocke S; Hausmann S; Steinman L; Wucherpfennig KW
    Semin Immunol; 1998 Feb; 10(1):57-67. PubMed ID: 9529656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system.
    Cannella B; Cross AH; Raine CS
    J Exp Med; 1990 Nov; 172(5):1521-4. PubMed ID: 2172438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis of multiple sclerosis and other neural autoimmune diseases].
    Lassmann H
    Verh Dtsch Ges Pathol; 1996; 80():109-15. PubMed ID: 9064993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evoked potentials in chronic inflammatory demyelinating polyneuropathy.
    Pakalnis A; Drake ME; Barohn RJ; Chakeres DW; Mendell JR
    Arch Neurol; 1988 Sep; 45(9):1014-6. PubMed ID: 2843153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of secure conduction by central demyelination.
    Smith KJ; McDonald WI; Blakemore WF
    Trans Am Neurol Assoc; 1979; 104():25-9. PubMed ID: 553424
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoimmune neuropathies.
    Pollard JD
    Electroencephalogr Clin Neurophysiol Suppl; 1987; 39():128-34. PubMed ID: 3477420
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunopathogenesis of the central nervous pattern of alterations. Attempt at a synoptic interpretation.
    Seitelberger F
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:37-40. PubMed ID: 5373035
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of nitric oxide production for down-regulation of CNS inflammation and demyelination.
    Brenner T; Pinto F; Abramsky O; Gallily R
    Prog Brain Res; 2001; 132():499-506. PubMed ID: 11545014
    [No Abstract]   [Full Text] [Related]  

  • 20. Demyelination--background and mechanisms. Kyoto, Japan, 9-11 September 1990.
    Kirk J
    J Neuroimmunol; 1991 Apr; 32(1):87-94. PubMed ID: 1672131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.